Evidence map›Paper›PMID 34623417›Full record

ArticleFamily practice2022

The use and safety of corticosteroid injections for shoulder pain in general practice: a retrospective cohort study.

Pieter F van Doorn, Dieuwke Schiphof, Rianne M Rozendaal, Ramon P G Ottenheijm, Johan van der Lei, Patrick J E Bindels, Evelien I T de Schepper

Open access · hybridAbstract read
In one paragraph

Article in Family practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pieter F van DoornDepartment of General practice, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-3208-3475
Dieuwke SchiphofDepartment of General practice, Erasmus Medical Center, Rotterdam, The Netherlands.
Rianne M RozendaalDepartment of General practice, Erasmus Medical Center, Rotterdam, The Netherlands.
Ramon P G OttenheijmDepartment of Family Medicine, CAPHRI Care and Public Health Research Institute, Maastricht, The Netherlands.ORCID 0000-0002-8816-2877
Johan van der LeiDepartment of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands.
Patrick J E BindelsDepartment of General practice, Erasmus Medical Center, Rotterdam, The Netherlands.
Evelien I T de SchepperDepartment of General practice, Erasmus Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGuidelines for shoulder pain in general practice recommend treatment with corticosteroid injections (CSI) if initial pain management fails. However, little is known about the actual use and safety of CSIs in treatment by general practitioners (GP).

objectiveThe objective of this study was to gain insight into the use and safety of CSIs for patients with a new episode of shoulder pain in general practice.

methodsA retrospective cohort study was conducted using a healthcare database containing the electronic medical records of approximately 200,000 patients in general practice. A search algorithm was constructed to identify patients with a new episode of shoulder pain between January 2012 and December 2017. Data on the use of CSIs in 2 random samples (n = 1,000) were manually validated for a 12-month period after the diagnosis.

resultsIn total, 26% of the patients with a new episode of shoulder pain received a CSI. The patient's age (OR 1.03, 95% CI 1.02-1.04) and a history of shoulder pain (OR 1.52, 95% CI 1.13-2.12) were significantly associated with the administration of a CSI. Half of the patients received the CSI in the first consultation. The patient's age was positively associated with the likelihood of receiving the CSI in the first consultation (OR 1.01, 95% CI 1.00-1.02). No serious adverse reactions were recorded by the GP.

conclusionIn contrast to the guidelines, CSIs were frequently administered in the first consultation. Older patients and patients with a history of shoulder pain were more likely to receive a CSI for shoulder pain.

Indexed as

General PracticeShoulder PainAdrenal Cortex HormonesFamily PracticeHumansRetrospective StudiesAdrenal Cortex Hormonescorticosteroid injectionelderlygeneral practiceprimary careshoulder painside effects

Identifiers

PMID34623417
PMCPMC9155165
OpenAlexW3204113496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.